Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.
Sponsor: Complejo Hospitalario Universitario de Badajoz
Summary
An open longitudinal observational study, non-randomized, which will include the adult population, attended by the SES, in which preference will be given to those patients under treatment with drugs that can produce relevant adverse effects. It is a naturalistic study in which no pharmacological or other type of intervention will be carried out, only the information recommended in the drug data sheet (pharmacogenetic biomarkers, relevant interactions and clinical contraindications) will be provided.
Official title: Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service. Population Cohort [MedeA21].
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
6445
Start Date
2021-05-26
Completion Date
2024-12-31
Last Updated
2024-09-23
Healthy Volunteers
Yes
Conditions
Locations (1)
Complejo Hospitalario Universitario de Badajoz
Badajoz, Spain